Literature DB >> 27824819

Shapeshifters in cancer: How some tumor cells change phenotype to evade therapy.

Amanda B Keener.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27824819     DOI： 10.1038/nm1116-1194

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  10 in total

1.  Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets.

Authors:  Himisha Beltran; David S Rickman; Kyung Park; Sung Suk Chae; Andrea Sboner; Theresa Y MacDonald; Yuwei Wang; Karen L Sheikh; Stéphane Terry; Scott T Tagawa; Rajiv Dhir; Joel B Nelson; Alexandre de la Taille; Yves Allory; Mark B Gerstein; Sven Perner; Kenneth J Pienta; Arul M Chinnaiyan; Yuzhuo Wang; Colin C Collins; Martin E Gleave; Francesca Demichelis; David M Nanus; Mark A Rubin
Journal:  Cancer Discov       Date:  2011-11       Impact factor: 39.397

2.  Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation.

Authors:  Jennifer Landsberg; Judith Kohlmeyer; Marcel Renn; Tobias Bald; Meri Rogava; Mira Cron; Martina Fatho; Volker Lennerz; Thomas Wölfel; Michael Hölzel; Thomas Tüting
Journal:  Nature       Date:  2012-10-10       Impact factor: 49.962

3.  Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature.

Authors:  Keith S Hoek; Natalie C Schlegel; Patricia Brafford; Antje Sucker; Selma Ugurel; Rajiv Kumar; Barbara L Weber; Katherine L Nathanson; David J Phillips; Meenhard Herlyn; Dirk Schadendorf; Reinhard Dummer
Journal:  Pigment Cell Res       Date:  2006-08

4.  N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer.

Authors:  Etienne Dardenne; Himisha Beltran; Matteo Benelli; Kaitlyn Gayvert; Adeline Berger; Loredana Puca; Joanna Cyrta; Andrea Sboner; Zohal Noorzad; Theresa MacDonald; Cynthia Cheung; Ka Shing Yuen; Dong Gao; Yu Chen; Martin Eilers; Juan-Miguel Mosquera; Brian D Robinson; Olivier Elemento; Mark A Rubin; Francesca Demichelis; David S Rickman
Journal:  Cancer Cell       Date:  2016-10-10       Impact factor: 31.743

5.  Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer.

Authors:  Irfan A Asangani; Vijaya L Dommeti; Xiaoju Wang; Rohit Malik; Marcin Cieslik; Rendong Yang; June Escara-Wilke; Kari Wilder-Romans; Sudheer Dhanireddy; Carl Engelke; Mathew K Iyer; Xiaojun Jing; Yi-Mi Wu; Xuhong Cao; Zhaohui S Qin; Shaomeng Wang; Felix Y Feng; Arul M Chinnaiyan
Journal:  Nature       Date:  2014-04-23       Impact factor: 49.962

6.  The transcription cofactor c-JUN mediates phenotype switching and BRAF inhibitor resistance in melanoma.

Authors:  Rachel Ramsdale; Robert N Jorissen; Frederic Z Li; Sheren Al-Obaidi; Teresa Ward; Karen E Sheppard; Patricia E Bukczynska; Richard J Young; Samantha E Boyle; Mark Shackleton; Gideon Bollag; Georgina V Long; Eugene Tulchinsky; Helen Rizos; Richard B Pearson; Grant A McArthur; Amardeep S Dhillon; Petranel T Ferrao
Journal:  Sci Signal       Date:  2015-08-18       Impact factor: 8.192

Review 7.  The role of phenotypic plasticity in the escape of cancer cells from targeted therapy.

Authors:  Michael F Emmons; Fernanda Faião-Flores; Keiran S M Smalley
Journal:  Biochem Pharmacol       Date:  2016-06-25       Impact factor: 5.858

8.  Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq.

Authors:  Itay Tirosh; Benjamin Izar; Sanjay M Prakadan; Marc H Wadsworth; Daniel Treacy; John J Trombetta; Asaf Rotem; Christopher Rodman; Christine Lian; George Murphy; Mohammad Fallahi-Sichani; Ken Dutton-Regester; Jia-Ren Lin; Ofir Cohen; Parin Shah; Diana Lu; Alex S Genshaft; Travis K Hughes; Carly G K Ziegler; Samuel W Kazer; Aleth Gaillard; Kellie E Kolb; Alexandra-Chloé Villani; Cory M Johannessen; Aleksandr Y Andreev; Eliezer M Van Allen; Monica Bertagnolli; Peter K Sorger; Ryan J Sullivan; Keith T Flaherty; Dennie T Frederick; Judit Jané-Valbuena; Charles H Yoon; Orit Rozenblatt-Rosen; Alex K Shalek; Aviv Regev; Levi A Garraway
Journal:  Science       Date:  2016-04-08       Impact factor: 47.728

9.  Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer.

Authors:  Himisha Beltran; Davide Prandi; Juan Miguel Mosquera; Matteo Benelli; Loredana Puca; Joanna Cyrta; Clarisse Marotz; Eugenia Giannopoulou; Balabhadrapatruni V S K Chakravarthi; Sooryanarayana Varambally; Scott A Tomlins; David M Nanus; Scott T Tagawa; Eliezer M Van Allen; Olivier Elemento; Andrea Sboner; Levi A Garraway; Mark A Rubin; Francesca Demichelis
Journal:  Nat Med       Date:  2016-02-08       Impact factor: 53.440

10.  MITF and c-Jun antagonism interconnects melanoma dedifferentiation with pro-inflammatory cytokine responsiveness and myeloid cell recruitment.

Authors:  Stefanie Riesenberg; Angela Groetchen; Robert Siddaway; Tobias Bald; Julia Reinhardt; Denise Smorra; Judith Kohlmeyer; Marcel Renn; Bengt Phung; Pia Aymans; Tobias Schmidt; Veit Hornung; Irwin Davidson; Colin R Goding; Göran Jönsson; Jennifer Landsberg; Thomas Tüting; Michael Hölzel
Journal:  Nat Commun       Date:  2015-11-04       Impact factor: 14.919
  10 in total
  4 in total

Review 1.  Phenotypic Plasticity, Bet-Hedging, and Androgen Independence in Prostate Cancer: Role of Non-Genetic Heterogeneity.

Authors:  Mohit Kumar Jolly; Prakash Kulkarni; Keith Weninger; John Orban; Herbert Levine
Journal:  Front Oncol       Date:  2018-03-06       Impact factor: 6.244

2.  Human Epidermal Growth Factor Receptor 2-Subtype Invasive Ductal Carcinoma Recurring as Basal-Human Epidermal Growth Factor Receptor 2-Subtype Squamous Cell Carcinoma.

Authors:  Jeongshin An; Youngeun Yoo; Hyun Goo Kim; Joohyun Woo; Kyoung Eun Lee; Hyungju Kwon; Woosung Lim; Sun Hee Sung; Nam Sun Paik; Byung-In Moon
Journal:  J Breast Cancer       Date:  2019-07-03       Impact factor: 3.588

3.  A Transient Metabolic State in Melanoma Persister Cells Mediated by Chemotherapeutic Treatments.

Authors:  Prashant Karki; Vahideh Angardi; Juan C Mier; Mehmet A Orman
Journal:  Front Mol Biosci       Date:  2022-01-27

Review 4.  Role of Hypoxic Stress in Regulating Tumor Immunogenicity, Resistance and Plasticity.

Authors:  Stéphane Terry; Rania Faouzi Zaarour; Goutham Hassan Venkatesh; Amirtharaj Francis; Walid El-Sayed; Stéphanie Buart; Pamela Bravo; Jérome Thiery; Salem Chouaib
Journal:  Int J Mol Sci       Date:  2018-10-06       Impact factor: 5.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.